Cure.

💡 AI in Digital Health: 2025 Funding Landscape 🔬 For the first time, AI-powered startups now account for a majority of digital health funding according to a recent analysis by Rock Health. These companies, deeply embedded in clinical workflows—from drug discovery to documentation—are leading the capital surge. 🚀 Notable numbers: AI startups secured 62% of total digital health venture funding in H1 2025 Out of the top nine biggest deals, eight went to AI-native companies like: Truveta ($320M), Abridge ($300M, Series E; also raised $250M in Series D), Innovaccer ($275M) 🏥 The broader trends in digital health show that investors are focusing on fewer, but larger deals, and ones that demonstrate “proof points,” that technology can bring validated improvements to patient care, according to the report. Read more: https://lnkd.in/dRkk9_nN ✍️Ryan Flinn

🚀 Turning Diagnosis into Disruption: How PCOS Sparked One Founder’s Bold Mission to Transform Women’s Health When Ali Chappell, PhD, MS, RD, was diagnosed with PCOS, she didn’t just seek better answers, she built them. What began as a personal health crisis led to deep research, clinical trials, and the launch of Lilli Health, a platform aiming to be a “dietitian in your pocket” for the millions of women sidelined by traditional care. 💡 Her journey is a powerful example of patient-led innovation: • From frustration to funding • From symptoms to solutions • From personal experience to public impact 👉 Learn how she built her dream app, secured investment, and is now giving back to the community that inspired it all. 🔗 https://lnkd.in/d-a-svGj #WomensHealth #PCOS #DigitalHealth #HealthcareInnovation #FounderStory #CureVoices ✍️Cathy Cassata

🚀 Reimagining Pediatric Care and Who Gets Access to It At Boston Community Pediatrics, Robyn Riseberg is proving that innovation in healthcare isn’t just about technology — it’s about equity, wraparound support, and rethinking the very structure of care delivery. By blending private-practice quality with nonprofit mission, this pediatrician-turned-entrepreneur and her team are setting a new standard for how to care for underserved families. Read how this bold model is reshaping pediatrics: https://lnkd.in/gpbi3gny [Portions of this story were derived from Riseberg and Life Science Cares, Inc. presentation at BIO International Convention in June 2025]

🚨 Supreme Court Ruling Alert: What It Really Means for Healthcare Founders Big news: The Supreme Court has upheld the ACA’s preventive care mandate—protecting coverage for cancer screenings, PrEP, and more. But what does that actually mean for healthcare entrepreneurs building solutions in diagnostics, virtual care, and benefits navigation? ➡️ Read the full breakdown: https://lnkd.in/eXHbpNBj ✍️  Ryan Flinn

💡 FDA Approval Tip #7: Don’t Overshare. During a Women's Health Week (previously SiS) event hosted at Cure, four entrepreneurs revealed lessons from their FDA experiences, from unexpected reclassifications to trial redesigns to funding gaps. →Enlist MedTech experts to help. In addition to the hard skills, a quality expert can counsel you through the ups and downs that are all part of the FDA experience. “They’ll say, ‘I know you're frustrated. That's how these things work,” said Eric Dy, PhD, Co-Founder and CEO of Bloomlife Inc. →Involve the FDA as early as possible. “You don’t want to have the FDA think too hard about it. They’re looking for this? Cool, check it off. They need this? Cool, check it off. You want to make the process go faster. Every time you delay it, you’re costing yourself time and money,” said Cindy Belardo, Co-Founder and CEO of Sunny, the first FDA-cleared menstrual cup and applicator. →Get creative if funding is tight. “Because we had limited funding, we invited 100 women to our local rec center and gave them each $20 for participating. We weren’t breaking any rules. It was just a strategic, cost-effective way to do it," said Amy Beckley PhD of Proov, an at-home hormone testing platform to help women facing infertility. →“Being first at anything means you’re at the mercy of the ever-changing discoveries of the agency,” pointed out Trena Depel Vice President of Regulatory, Clinical and Quality at Teal Health, a self-collection vaginal device for cervical cancer screening. “Their knowledge is evolving, so your tactics and strategy have to be flexible to evolve with them.” 🔗 Read more https://lnkd.in/g6tCjiAC ✍️ Susan Schulz Wuornos #healthcarestartups #FDAapproval #digitalhealth #biotech #regulatorystrategy #founderlessons #womenshealth

🚨 Calling all healthcare startups and innovators!🚨 Think your startup has what it takes to shape the future of health? Applications are now open for the King Faisal & Davos of Healthcare Innovation Challenge — a global competition hosted by King Faisal Specialist Hospital and Research Center (KFSHRC), Cure, and C3 International. This is your chance to: ✅ Pitch your groundbreaking solution within 8 critical healthcare domains at the C3 Davos of Healthcare™ in NYC ✅ Secure a proof of concept with KFSHRC in Saudi Arabia 📅 Deadline to apply: July 25 🔗Apply now: https://lnkd.in/e9pu7Yr9 👉 Swipe to see more

🚀 Are you building a women’s health startup? Executives say be ready to pivot — and earn trust of your audience. During Women's Health Week (previously SiS) event hosted at Cure, four founders shared how trial, error, and trust shaped their go-to-market journeys: → As clinical trials were set to begin, COVID-19 hit and fertility clinics were suddenly unable to see patients in person. Within two weeks of the shutdown, we built a compliant portal where clinicians could view their patients’ data in real time," said Aparna (Amy) Divaraniya, PhD, CEO and Founder of Oova. → “While investors may advise to quickly churn out generic content using ChatGPT, “Women are smart, and they’ve been gaslit before.” So, invest in thoughtful content that supports your company’s point of view and mission. Be sure to include expert voices from clinicians to build your reputation as an authority. Alessandra Henderson, Co-Founder Elektra Health on why education and authentic content matter. 💡 → Jessica Bell van der Wal, CEO of Frame, emphasized access gaps: “So many counties around the U.S. don't have a fertility clinic or even an OB-GYN,” Bell van der Wal pointed out. So we decided to diversify its GTM to reach provider types across the spectrum." → Kaitlin Christine, CEO of Gabbi, shared her biggest lesson: “Be ruthlessly focused. Pick a path, set metrics, and run at it like hell for a defined period of time. If it’s not working by X date, pivot 🎯 What is the universal takeaway? Trust is your most valuable currency — and word-of-mouth is your strongest growth engine. Read more for advice on how trial, error, and trust shaped their journeys. https://lnkd.in/eYhpQKkf #wewillcure #womenshealth #entrepreneurs #gtm

💲 Raising capital for a healthcare startup isn't easy, especially in women’s health, where innovation is often ignored.   In our latest founder spotlight video, Dr. Piraye Beim, Founder and CEO of Celmatix Therapeutics, shares how she overcame investor skepticism, demonstrated both the science and the business case, and remained resilient despite VC roadblocks that eventually led to her generating over $100M for Celmatix.   💥 Dr. Beim's story is a must-watch for any healthcare entrepreneur struggling to secure funding and exploring alternative funding options. Watch then for more information on funding options; read: Beyond VC: 6 Ways to Fund Your Healthcare Startup, where founders like Sylvia Kang  of Mira, Elena Rueda of Dama Health and Frederik Petursson Madsen of Cirqle Biomedical offer their advice on tapping alternative sources. https://lnkd.in/esucbvdr #vcfunding #alternativefunding #entrepreneuradvice

The Market’s Ready. The Science is Strong. So Where’s the Funding for IUD Innovation? 📉 The global IUD market hit $4.5 billion last year — with use by more than 160 million women. But innovation? Still stuck in the past. Cure’s Ryan Flinn chats with CEO Mary Beth Cicero from 3Daughters, a startup developing a frameless, magnetic nonhormonal IUD designed to reduce the insertion pain millions of women endure. She says the FDA is interested and the market is hungry for alternatives, but raising capital remains an uphill battle. Few VCs back women’s health — even fewer touch contraception. “It’s not our domain expertise,” Mary Beth Cicero hears again and again. 🚀 Despite the odds, 3Daughters has raised nearly $10M to advance the technology towards an IND filing — a milestone few startups in this space achieve. But one final hurdle remains: securing the last $1M to launch a phase 1 trial. ➡️ Read how Cicero is fighting a legacy of indifference: https://lnkd.in/eiNeaqJs #womenshealth #wewillcure #contraception #IUD

This week at #AspenHealthIdeas, Cure CEO Seema Kumar shared why funding innovation should never be an either/or conversation. During her panel, "Ensuring the Promises of Bold Science," Seema emphasized the critical need to combine public funding, private capital, and philanthropy to drive scientific progress. "We often overlook the power of ‘and.’ The conversation around NIH funding should not be framed as a choice between public investment or private capital—it must be both. Just as we diversify our financial portfolios to manage risk, we must teach the next generation to pursue multiple funding streams, blending non-dilutive, dilutive, and philanthropic sources. Institutions like Whitehead and Broad exist because private philanthropists recognized the gaps—and took action.” — Seema Kumar, CEO Cure. Watch more from Seema and the entire panel here: https://lnkd.in/eV8Fz2r9 The Aspen Institute Aaron F. Mertz, Ph.D. Jonathan Wosen, PhD Mohit Manrao, Mae Jemison